Rüdiger Göke

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

Rüdiger Göke, H. C. Fehmann, Thomas Linn et al. · Journal of Biological Chemistry · 1993 · 834 citations · Full text

Cross-linking Experiments, Glycobiology, Peptide Science +20

Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man

R. Eissele, Rüdiger Göke, Sebastian Willemer et al. · European Journal of Clinical Investigation · 1992 · 641 citations

Large Bowel, Immunocytochemical Technique, Specific Monoclonal Antibody +17

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats

Mads Tang‐Christensen, Philip J. Larsen, Rüdiger Göke et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1996 · 589 citations

Gastrointestinal Pharmacology, Food Restriction Schedule, Glucagon-like Peptide +22

Glucagon-Like Peptide-1 and Glucose-Dependent Insulin-Releasing Polypeptide Plasma Levels in Response to Nutrients

Christine Herrmann, Rüdiger Göke, Gerd Richter et al. · Digestion · 1995 · 588 citations

Nutrition, Glycobiology, G Corn Oil +17

Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites

Rüdiger Göke, Philip J. Larsen, Jens D. Mikkelsen et al. · European Journal of Neuroscience · 1995 · 467 citations

Glp‐1 Binding Sites, Synaptic Transmission, Glucagon-like Peptide +18